Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-06-28

FDA Approved: MYRBETRIQ — Original Application (Astellas Pharma US, Inc.)

View source ↗

Summary

FDA approved Mirabegron (Myrbetriq) from Astellas Pharma US for the original application, marking the initial approval for this product to treat overactive blad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Myrbetriq (mirabegron)

Snippet

ORIG AP for MYRBETRIQ (MIRABEGRON)